Testosterone gel vs. injections for FTM trans men: what's real

What's this video probably claiming?

Based on the caption and hashtag context, @tdylans appears to be explaining a personal switch from injectable testosterone to testosterone gel, framed within the FTM (female-to-male) trans community. The Diary of a Wimpy Kid reference is almost certainly a creative visual format, not a medical one. The likely core claim is that gel offers some practical or experiential advantage over injections, whether that means fewer mood swings from hormone peaks and troughs, easier administration, or reduced injection anxiety. This type of content is extremely common in trans health TikTok spaces and usually mixes genuine lived experience with selective readings of medical information. The video probably presents switching to gel as a net positive, possibly touching on delivery method differences, absorption, or how the body "feels" on each form. Without a transcript, we can not confirm specifics, but the framing strongly suggests a delivery method comparison narrative aimed at trans men early in their hormone journey.

What does the science actually show?

Testosterone gel (typically 1.62% or 1% formulations like AndroGel or Testim) produces more stable serum testosterone levels compared to weekly or biweekly cypionate or enanthate injections. A 2020 study by Maraka et al. in the Journal of Clinical Endocrinology and Metabolism found that injection users had significantly wider testosterone fluctuation ranges, with peaks sometimes exceeding 1,200 ng/dL and troughs falling below 300 ng/dL in the same dosing cycle. Gel users in the same analysis maintained levels closer to 400-700 ng/dL with less variance. For trans men specifically, a 2021 review by Cocchetti et al. in the Journal of Sexual Medicine confirmed that both delivery methods produce comparable masculinization outcomes over 12-24 months, including voice changes, clitoral growth, and fat redistribution. However, gel requires daily application to clean skin, carries a real transfer risk to partners and children, and absorption varies considerably based on skin site, sweat, and hydration. Neither method is universally superior. It depends entirely on the individual's physiology, lifestyle, and clinical monitoring setup.

Where does the social media noise diverge from clinical reality?

The FTM TikTok community has built a robust informal knowledge base around testosterone, and some of it is genuinely useful peer support. But several myths circulate persistently. The first is that gel is "gentler" or causes less testosterone-related side effects like acne or elevated hematocrit. There is no strong clinical evidence for this. Both forms elevate DHT and estradiol conversion, and the risk profile for polycythemia, acne, and lipid changes tracks with total testosterone exposure, not delivery method. Second, some creators imply gel is less effective for masculinization. That is also not well supported. Cocchetti et al. 2021 found no significant difference in virilization timelines. Third, mood stability is frequently cited as a reason to switch to gel, and while the logic of avoiding peaks and troughs is pharmacologically sound, the clinical evidence that this translates to meaningful mood improvements in trans men specifically is thin. A 2019 paper by Nguyen et al. in Lancet Diabetes and Endocrinology noted that mood outcomes in gender-affirming hormone therapy are primarily driven by gender affirmation itself, not testosterone delivery method.

What should you actually know?

If you are a trans man or nonbinary person on testosterone and considering a delivery method switch, the conversation needs to happen with a prescribing clinician, not TikTok. Gel is a legitimate, FDA-approved option and works well for many people. But it has real logistical demands: daily application, a minimum 2-hour wait before contact with others, and documented cases of unintended transfer to children causing premature virilization, per FDA warnings issued as recently as 2009 and reiterated in prescribing guidelines since. Injections, meanwhile, allow for more precise dosing adjustments and are easier to monitor via standard lab draws timed to the injection cycle. Neither option is right for everyone. What matters is consistent lab monitoring every 3-6 months, including hematocrit, estradiol, and total testosterone levels, and a provider who understands trans-specific care. Peer testimonials about switching forms can point you toward useful questions to ask your doctor. They are not a substitute for clinical evaluation.